SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 57 filers reported holding SYNTHETIC BIOLOGICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $48,000 | -68.2% | 201,959 | -57.3% | 0.00% | – |
| Q1 2018 | $151,000 | -63.2% | 473,497 | -41.4% | 0.00% | -100.0% |
| Q4 2017 | $410,000 | -59.5% | 808,058 | -25.5% | 0.00% | -50.0% |
| Q3 2017 | $1,012,000 | +38.8% | 1,084,421 | -15.9% | 0.00% | +100.0% |
| Q2 2017 | $729,000 | +215.6% | 1,289,833 | +252.6% | 0.00% | – |
| Q1 2017 | $231,000 | -59.9% | 365,774 | -51.6% | 0.00% | -100.0% |
| Q4 2016 | $576,000 | +526.1% | 755,028 | +1378.5% | 0.00% | – |
| Q2 2016 | $92,000 | -67.7% | 51,067 | -57.8% | 0.00% | -100.0% |
| Q1 2016 | $285,000 | +96.6% | 120,873 | +90.6% | 0.00% | – |
| Q4 2015 | $145,000 | +123.1% | 63,412 | +123.1% | 0.00% | – |
| Q3 2015 | $65,000 | -31.6% | 28,428 | -14.3% | 0.00% | – |
| Q2 2015 | $95,000 | +1.1% | 33,169 | -22.8% | 0.00% | – |
| Q1 2015 | $94,000 | – | 42,945 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 13,238,268 | $6,726,000 | 0.58% |
| MSD Partners, L.P. | 4,118,402 | $2,092,000 | 0.11% |
| 683 Capital Management, LLC | 1,500,000 | $762,000 | 0.06% |
| Vivaldi Capital Management LP | 101,145 | $51,000 | 0.04% |
| Alyeska Investment Group, L.P. | 5,000,000 | $2,540,000 | 0.02% |
| BARD ASSOCIATES INC | 56,499 | $29,000 | 0.01% |
| FRANKLIN STREET ADVISORS INC /NC | 126,000 | $64,000 | 0.01% |
| Virtu Financial LLC | 299,577 | $152,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 46,981 | $24,000 | 0.01% |
| Stanley-Laman Group, Ltd. | 60,323 | $31,000 | 0.01% |